Toray Industries, Inc.
↗Nihonbashi Mitsui Tower, 1-1, Nihonbashi-Muromachi 2-chome, Chūō, Tokyo, Japan
Toray Industries is a multinational Japanese corporation founded in 1926 (originally as Toyo Rayon) that combines nanotechnology with core competencies in organic synthetic chemistry, polymer chemistry, and biochemistry. The company develops and manufactures a diverse portfolio of products including fibers & textiles, plastics & chemicals, IT-related products, carbon fiber composite materials, pharmaceuticals & medical products, and environment & engineering solutions. In pharmaceuticals, Toray pursues "Toray-style drug discovery" through persistent pursuit of unmet medical needs, applying advanced materials technology and business expertise in drug discovery, biotools, and veterinary medicines. The company operates globally with presence in 26 countries and regions.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals & Biotechnology
Sub-Industry:Integrated pharmaceutical manufacturer with oncology, immunology, and specialty therapeutics focus
SIZE & FINANCIALS
Employees:10000+
Revenue:$16.8B (TTM)
Founded:1926
Ownership:public
Status:operating
STOCK
Exchange:Tokyo Stock Exchange & NASDAQ (ADR)
Ticker:3402 (TSE), TRYIY (NASDAQ/OTC)
Market Cap:$10.6 billion
PIPELINE
Stage:Phase 1 to Phase 2
Lead Drug Stage:Phase 2 (TRK-950 for gastric cancer)
Modalities:Small molecule, Monoclonal antibodies, Interferon-based biologics, Prostacyclin derivatives, Nucleic acid medicines (siRNA), Oral formulations
Active Trials:44
Trial Phases:Phase 1: 10 | Phase 2: 12 | Phase 3: 8 | Phase 4: 14
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Toray Medical Co., Ltd., Toray Engineering, Toray Plastics (America), Inc., Toray Composite Materials America, Inc., Toray Fluorofibers (America), Inc., Toray Membrane USA, Zoltek (wholly owned)
Key Partnerships:BONAC Corporation - TRK-250 (BNC-1021) development for IPF, 3SBio - Remitch distribution/commercialization in China
COMPETITION
Position:Niche Player (focused on specialized therapeutic areas with limited geographic reach)
Competitors:Astellas Pharma, Daiichi Sankyo, Sanofi, Amgen, BeiGene, Regeneron Pharmaceuticals, Eisai, Takeda Pharmaceutical +2 more
LEADERSHIP
Key Executives:
Akihiro Nikkaku - Chairman & President
Tetsuya Tsunekawa - Executive Vice President, Board Member
Kenichiro Miki - Senior Vice President
Board Members:Akihiro Nikkaku, Tetsuya Tsunekawa, Kenichiro Miki
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Toray Industries, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Toray Industries, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.